These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11262079)

  • 21. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
    Storer RJ; Goadsby PJ
    Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
    Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C
    Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
    Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors.
    Audinot V; Newman-Tancredi A; Cussac D; Millan MJ
    Neuropsychopharmacology; 2001 Sep; 25(3):410-22. PubMed ID: 11522469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD
    Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
    Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
    J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
    McCall RB; Huff R; Chio CL; TenBrink R; Bergh CL; Ennis MD; Ghazal NB; Hoffman RL; Meisheri K; Higdon NR; Hall E
    Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity.
    Willems E; De Vries P; Heiligers JP; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):212-9. PubMed ID: 9750007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
    Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.
    Glen RC; Martin GR; Hill AP; Hyde RM; Woollard PM; Salmon JA; Buckingham J; Robertson AD
    J Med Chem; 1995 Sep; 38(18):3566-80. PubMed ID: 7658443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.
    Ennis MD; Ghazal NB; Hoffman RL; Smith MW; Schlachter SK; Lawson CF; Im WB; Pregenzer JF; Svensson KA; Lewis RA; Hall ED; Sutter DM; Harris LT; McCall RB
    J Med Chem; 1998 Jun; 41(13):2180-3. PubMed ID: 9632349
    [No Abstract]   [Full Text] [Related]  

  • 39. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.
    Matsubara T; Moskowitz MA; Byun B
    Br J Pharmacol; 1991 Sep; 104(1):3-4. PubMed ID: 1664765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
    J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.